<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4712</id>
  <title>T3D4658</title>
  <common-name>Dibenz(b,F)-1,4-oxazepine</common-name>
  <description>Dibenz(b,F)-1,4-oxazepine, also known as CR gas and dibenzoxazepine, is an incapacitating agent and a lachrymatory agent. It was developed by the British Ministry of Defence as a riot control agent in the late 1950s and early 1960s. Dibenz(b,F)-1,4-oxazepine is a lachrymatory agent (LA), exerting its effects through activation of the TRPA1 channel. It is a suspected carcinogen. It is toxic, but less so than CS gas (2-chlorobenzalmalononitrile), by ingestion and exposure. However, it can be lethal in large quantities. In a poorly ventilated space, an individual may inhale a lethal dose within minutes. Death is caused by asphyxiation and pulmonary edema. The effect of CR is long-term and persistent. CR can persist on surfaces, especially porous ones, for up to 60 days.</description>
  <cas>257-07-8</cas>
  <pubchem-id>9213</pubchem-id>
  <chemical-formula>C13H9NO</chemical-formula>
  <weight nil="true"/>
  <appearance>Pale yellow crystalline solid</appearance>
  <melting-point>73°C</melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility></solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure></route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity></mechanism-of-toxicity>
  <metabolism></metabolism>
  <toxicity></toxicity>
  <lethaldose></lethaldose>
  <carcinogenicity>Not listed by IARC.</carcinogenicity>
  <use-source></use-source>
  <min-risk-level></min-risk-level>
  <health-effects></health-effects>
  <symptoms></symptoms>
  <treatment></treatment>
  <created-at type="dateTime">2014-09-08T02:41:29Z</created-at>
  <updated-at type="dateTime">2026-04-03T19:32:46Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>http://en.wikipedia.org/wiki/CR_gas</wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id></kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id></chebi-id>
  <biocyc-id></biocyc-id>
  <ctd-id></ctd-id>
  <stitch-id></stitch-id>
  <drugbank-id></drugbank-id>
  <pdb-id></pdb-id>
  <actor-id></actor-id>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>[H]C1=C([H])C([H])=C2N=C([H])C3=C([H])C([H])=C([H])C([H])=C3OC2=C1[H]</moldb-smiles>
  <moldb-formula>C13H9NO</moldb-formula>
  <moldb-inchi>InChI=1S/C13H9NO/c1-3-7-12-10(5-1)9-14-11-6-2-4-8-13(11)15-12/h1-9H</moldb-inchi>
  <moldb-inchikey>NPUACKRELIJTFM-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">195.2167</moldb-average-mass>
  <moldb-mono-mass type="decimal">195.068413915</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp></logp>
  <hmdb-id></hmdb-id>
  <chembl-id>CHEMBL1085100</chembl-id>
  <chemspider-id>8858</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003616</chemdb-id>
  <dsstox-id>DTXSID8059764</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaene</iupac>
</compound>
